Stay updated on Dolutegravir vs Efavirenz in Pregnant Women Clinical Trial
Sign up to get notified when there's something new on the Dolutegravir vs Efavirenz in Pregnant Women Clinical Trial page.

Latest updates to the Dolutegravir vs Efavirenz in Pregnant Women Clinical Trial page
- Check2 days agoChange DetectedThe site footer now displays revision v3.8.1 instead of v3.8.0.SummaryDifference0.0%

- Check9 days agoChange DetectedThe clinical-trial record is available again, with details on the completed HIV treatment study in pregnant women and their infants, including eligibility criteria, treatment arms, outcome measures, publications, and study documents.SummaryDifference95%

- Check16 days agoChange DetectedThe footer revision changes from v3.7.2 to v3.8.0; the study record remains inaccessible.SummaryDifference0.2%

- Check30 days agoChange DetectedA general notice about NIH’s terminology transition appears above the 403 error page. The site revision label changed from v3.7.1 to v3.7.2.SummaryDifference1%

- Check44 days agoChange DetectedThe footer's displayed ClinicalTrials.gov revision changed from v3.7.0 to v3.7.1; the page still shows a 403 Forbidden error.SummaryDifference0.2%

- Check58 days agoChange DetectedThe page now returns a 403 Forbidden error instead of the study details, indicating restricted access; a Home link is displayed on the error screen and the normal content is not reachable.SummaryDifference23%

Stay in the know with updates to Dolutegravir vs Efavirenz in Pregnant Women Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dolutegravir vs Efavirenz in Pregnant Women Clinical Trial page.